First Detection of DS-1-like G1P[8] Double-gene Reassortant Rotavirus Strains on The American Continent, Brazil, 2013

Imagem de Miniatura
Arquivos
art_LUCHS_First_Detection_of_DS1like_G1P8_Doublegene_Reassortant_Rotavirus_2019.PDF (2.66 MB)
Citações na Scopus
17
Tipo de produção
article
Data de publicação
2019
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
NATURE PUBLISHING GROUP
Autores
LUCHS, Adriana
CILLI, Audrey
KOMNINAKIS, Shirley Cavalcante Vasconcelos
CARMONA, Rita de Cassia Compagnoli
MORILLO, Simone Guadagnucci
TIMENETSKY, Maria do Carmo Sampaio Tavares
Citação
SCIENTIFIC REPORTS, v.9, article ID 2210, 7p, 2019
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Emergence of DS-1-like-G1P[8] rotavirus in Asia have been recently reported. We report for the first time the detection and the whole genome phylogenetic analysis of DS-1-like-G1P[8] strains in America. From 2013 to 2017, a total of 4226 fecal samples were screened for rotavirus by ELISA, PAGE, RT-PCR and sequencing. G1P[8] represented 3.7% (30/800) of all rotavirus-positive samples. DS-1-like-G1P[8] comprised 1.6% (13/800) detected exclusively in 2013, and Wa-like-G1P[8] comprised 2.1% (17/800) detected from 2013 to 2015. Whole genome sequencing confirmed the DS-1-like backbone I2-R2-C2-M2-A2-N2-T2-E2-H2. All genome segments of the Brazilian DS-1-like-G1P[8] strains clustered with those of Asian strains, and apart from African DS-1-like-G1P[8] strains. In addition, Brazilian DS-1-likeG1P[8] reassortants distantly clustered with DS-1-like backbone strains simultaneously circulating in the country, suggesting that the Brazilian DS-1-like-G1P[8] strains are likely imported from Asia. Two distinct NSP4 E2 genotype lineages were also identified, indicating the existence of a co-circulating pool of different DS-1-like G1P[8] strains. Surveillance systems must be developed to examine if RVA vaccines are still effective for the prevention against unusual DS-1-like-G1P[8] strains.
Palavras-chave
URI
https://observatorio.fm.usp.br/handle/OPI/31726
Referências
  1. Aida S, 2016, HELIYON, V2, DOI 10.1016/j.heliyon.2016.e00168
  2. Arana A, 2016, INFECT GENET EVOL, V44, P137, DOI 10.1016/j.meegid.2016.06.048
  3. Arista S, 2006, J VIROL, V80, P10724, DOI 10.1128/JVI.00340-06
  4. Beltrao K. I., 2016, REV BRAS ESTUD POPUL, V23, P61
  5. Cowley D, 2016, J GEN VIROL, V97, P403, DOI 10.1099/jgv.0.000352
  6. da Costa AC, 2017, EMERG INFECT DIS, V23, P1742, DOI 10.3201/eid2310.170307
  7. Deng XT, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv002
  8. Desai R, 2012, CLIN INFECT DIS, V55, pE28, DOI 10.1093/cid/cis443
  9. Desai R, 2011, MEM I OSWALDO CRUZ, V106, P907, DOI 10.1590/S0074-02762011000800002
  10. Doan YH, 2015, INFECT GENET EVOL, V34, P423, DOI 10.1016/j.meegid.2015.05.026
  11. Doro R, 2016, ACTA MICROBIOL IMM H, V63, P243, DOI 10.1556/030.63.2016.2.8
  12. Flannery B, 2013, VACCINE, V31, P1523, DOI 10.1016/j.vaccine.2013.01.004
  13. Fujii Y, 2014, INFECT GENET EVOL, V28, P426, DOI 10.1016/j.meegid.2014.08.001
  14. GENTSCH JR, 1992, J CLIN MICROBIOL, V30, P1365
  15. Gomez MM, 2014, INFECT GENET EVOL, V28, P486, DOI 10.1016/j.meegid.2014.09.012
  16. GOUVEA V, 1994, J CLIN MICROBIOL, V32, P1333
  17. GOUVEA V, 1990, J CLIN MICROBIOL, V28, P276
  18. Guntapong R, 2017, J MED VIROL, V89, P615, DOI 10.1002/jmv.24669
  19. Hall T.A., 1999, NUCL ACIDS S SER, V41, P95, DOI 10.1021/BK-1999-0734.CH008
  20. HERRING AJ, 1982, J CLIN MICROBIOL, V16, P473
  21. Jere KC, 2018, J VIROL, V92, DOI 10.1128/JVI.01246-17
  22. Kapikian A. Z, 1996, FIELDS VIROLOGY, P1625
  23. Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199
  24. Komoto S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148416
  25. Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI 10.1093/molbev/msw054
  26. Leite J. R. T, 1999, CHINA BRAZIL CHINESE
  27. LI BG, 1993, VIROLOGY, V196, P825, DOI 10.1006/viro.1993.1540
  28. Luchs A, 2016, ACTA TROP, V156, P87, DOI 10.1016/j.actatropica.2015.12.008
  29. Maes P, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-238
  30. da Silva MFM, 2015, INFECT GENET EVOL, V30, P206, DOI 10.1016/j.meegid.2014.12.030
  31. McDonald SM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000634
  32. Nakagomi T, 2017, ARCH VIROL, V162, P739, DOI 10.1007/s00705-016-3155-6
  33. Paternina-Caicedo A, 2015, VACCINE, V33, P3923, DOI 10.1016/j.vaccine.2015.06.058
  34. Perkins C, 2017, MICROBIOL RESOUR ANN, V5, DOI 10.1128/genomeA.01341-17
  35. Phan TG, 2007, J VIROL, V81, P10188, DOI 10.1128/JVI.00337-07
  36. Guerra SFS, 2016, J GEN VIROL, V97, P3131, DOI 10.1099/jgv.0.000626
  37. Yamamoto D, 2017, New Microbes New Infect, V18, P54, DOI 10.1016/j.nmni.2017.04.001
  38. Yamamoto SP, 2014, EMERG INFECT DIS, V20, P1030, DOI 10.3201/eid2006.131326

Coleções
Artigos e Materiais de Revistas Científicas - FM/MIP
Artigos e Materiais de Revistas Científicas - IMT
Artigos e Materiais de Revistas Científicas - LIM/46
Artigos e Materiais de Revistas Científicas - ODS/03